
zzso and psychosis are common in zzso disease and cause considerable zzso We attempted to delay or to prevent agitation and psychosis with the use of zzso sodium zzso 

To determine whether treatment with zzso could delay or prevent emergence of agitation or zzso 

A zzso randomized, zzso zzso trial of zzso zzso in 313 (of zzso zzso individuals with moderate zzso disease who had not yet experienced agitation or zzso The study was conducted from November 1, 2005, through March 31, 2009, at 46 sites in the United zzso 

Participants were randomly assigned to zzso treatment at a target dose of 10 to 12 zzso per zzso of body weight per day or zzso zzso for 24 months followed by a zzso period of zzso zzso zzso 

Time to emergence of clinically significant agitation or zzso 

A total of 122 participants zzso receiving zzso and 63 receiving zzso completed 24 months of treatment while taking study zzso 42 (27 receiving zzso and 15 receiving zzso reached 24 months having discontinued study zzso 150 reached month zzso There was no difference between groups in time to emergence of agitation or psychosis zzso zzso hazard ratio, zzso P zzso zzso There was no difference between groups in change on any secondary zzso The zzso group had higher rates of zzso gait zzso zzso zzso and zzso zzso participants underwent magnetic resonance imaging scans at baseline and 12 zzso the zzso group showed greater loss in zzso and zzso volume, accompanied by greater zzso expansion zzso zzso zzso 

zzso treatment did not delay emergence of agitation or psychosis or slow cognitive or functional decline in patients with moderate zzso disease and was associated with significant toxic zzso 

